Issue 18, 2024

An ordered mesoporous carbon–silica hybrid for the detection of the antiviral drug ribavirin in clinical samples

Abstract

Ribavirin (RIB) is widely used for the treatment of viral diseases such as herpes, hepatitis C, and Lassa fever. Moreover, to control the spread of COVID-19, the consumption of antiviral medicines, including RIB, has increased significantly worldwide. By combining ordered mesoporous carbon with silica nanoparticles via ultrasound, we synthesized silica/ordered mesoporous carbon (SiO2–OMC) hybrid composites that show excellent electrochemical performance. The hybrid composite was found to contain spherical SiO2 nanoparticles having diameters ranging from 21 to 29 nm. A sensor comprising a carbon paste electrode and SiO2–OMC (SiO2–OMC/CPE) facilitated the ultrasensitive and selective detection of RIB at an oxidation potential of 0.71 V, having a linear range of 0.1–40 μmol L−1, limit of detection of 0.067 μmol L−1, and sensitivity of 1.969 μA μmol−1 L. Furthermore, the results indicate that charge transfer at the interface of the SiO2–OMC hybrid results in a synergistic effect compared to OMC and SiO2 alone. The advantages include the potential for regenerating the sensor surface, rapid and facile production, and suitability for the detection of RIB in capsule, human plasma, and urine samples, making SiO2–OMC/CPE a promising interface for bioelectrochemical applications.

Graphical abstract: An ordered mesoporous carbon–silica hybrid for the detection of the antiviral drug ribavirin in clinical samples

Supplementary files

Article information

Article type
Paper
Submitted
25 May 2024
Accepted
15 Jul 2024
First published
29 Jul 2024
This article is Open Access
Creative Commons BY-NC license

Nanoscale Adv., 2024,6, 4657-4663

An ordered mesoporous carbon–silica hybrid for the detection of the antiviral drug ribavirin in clinical samples

A. H. Ali Naghian, Z. Hashemi, F. Chekin and N. Saleh, Nanoscale Adv., 2024, 6, 4657 DOI: 10.1039/D4NA00435C

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements